Clinical Trials Browser

Phase 1/2 × Alpelisib × 30 days × Clear all

NCT01872260 2026-04-01

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Phase 1/2 Active not recruiting

Breast Neoplasms